Apricot-l: Results of a biomarker-based phase II randomized placebo-controlled study of apricoxib in combination with erlotinib in non-small cell lung cancer (NSCLC) patients.
B. J. Gitlitz
No relevant relationships to disclose
E. D. Bernstein
No relevant relationships to disclose
G. P. Keogh
No relevant relationships to disclose
E. S. Santos
No relevant relationships to disclose
G. A. Otterson
Consultant or Advisory Role - Celgene; Genentech
Research Funding - Celgene; Genentech; Pfizer
G. Milne
Research Funding - Tragara Pharmaceuticals
M. Syto
Employment or Leadership Position - Tragara Pharmaceuticals
Stock Ownership - Tragara Pharmaceuticals
S. L. Zaknoen
Employment or Leadership Position - Tragara Pharmaceuticals
Stock Ownership - Tragara Pharmaceuticals